This review article from Frontiers in Immunology explores the role of C-reactive protein (CRP) as a biomarker of inflammation and its potential as a therapeutic target in various chronic diseases such as cardiovascular disease, cancer, and autoimmune disorders. Elevated CRP levels have been linked to worse clinical outcomes, prompting interest
